HSCS (HeartSciences Inc. Common Stock) Stock Analysis - Analyst Ratings

HeartSciences Inc. Common Stock (HSCS) is a publicly traded Healthcare sector company. As of May 21, 2026, HSCS trades at $1.99 with a market cap of $5.92M and a P/E ratio of -0.40. HSCS moved +0.00% today. Year to date, HSCS is -37.34%; over the trailing twelve months it is -57.02%. Its 52-week range spans $1.77 to $6.47. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces HSCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate HSCS?

2 analysts cover HSCS: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $10.00.

HSCS Key Metrics

Key financial metrics for HSCS
MetricValue
Price$1.99
Market Cap$5.92M
P/E Ratio-0.40
EPS$-4.61
Dividend Yield0.00%
52-Week High$6.47
52-Week Low$1.77
Volume145
Avg Volume0
Revenue (TTM)$8.67K
Net Income$-8.49M
Gross Margin57.92%

HSCS Analyst Consensus

2 analysts cover HSCS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.

Latest HSCS News

Recent HSCS Insider Trades

  • HILZ MARK T sold 4.42K (~$15.62K) on Jul 29, 2025.

Common questions about HSCS

What do analysts rate HSCS?
2 analysts cover HSCS: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $10.00.
Does Rallies show HSCS price targets?
Yes. Rallies tracks HSCS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is HSCS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HSCS. It does not provide personalized investment advice.
HSCS

HSCS